Manager × security

Eversept Partners, LP VERA holdings history

Who else holds this security? →

VERA THERAPEUTICS INC · CUSIP 92337R101 · CIK 1697013

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Eversept Partners, LP reported 2.21M VERA (shares), valued at $94.95M, or 5.18% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
5.18%
Shares
2.21M
2,212,770
Reported value
$94.95M
USD

Shares increased 1.82%; reported value increased 8.60%, and weight changed -0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20265.18%2,212,770SEC filing ↗Filed Aug 14, 2026
Q1 20265.76%2,173,286SEC filing ↗Filed May 15, 2026
Q4 20258.72%3,072,304SEC filing ↗Filed Feb 17, 2026
Q3 20256.25%2,807,836SEC filing ↗Filed Nov 14, 2025
Q2 20255.66%2,383,055SEC filing ↗Filed Aug 14, 2025
Q1 20255.16%1,898,804SEC filing ↗Filed May 15, 2025
Q4 20246.98%1,600,015SEC filing ↗Filed Feb 14, 2025
Q3 20246.95%2,050,157SEC filing ↗Filed Nov 14, 2024
Q2 20245.66%2,043,214SEC filing ↗Filed Aug 14, 2024
Q1 20245.88%1,823,781SEC filing ↗Filed May 15, 2024
Q4 20232.89%1,914,830SEC filing ↗Filed Feb 14, 2024
Q3 20232.25%1,478,489SEC filing ↗Filed Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20232.25%1,478,489$20.27MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 14, 2023
Q4 20232.89%1,914,830$29.45MShares increased 29.51%; reported value increased 45.29%, and weight changed +0.64 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2024
Q1 20245.88%1,823,781$78.64MShares decreased 4.75%; reported value increased 167.03%, and weight changed +2.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20245.66%2,043,214$73.92MShares increased 12.03%; reported value decreased 6.00%, and weight changed -0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20246.95%2,050,157$90.62MShares increased 0.34%; reported value increased 22.58%, and weight changed +1.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20246.98%1,600,015$67.66MShares decreased 21.96%; reported value decreased 25.33%, and weight changed +0.03 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20255.16%1,898,804$45.61MShares increased 18.67%; reported value decreased 32.60%, and weight changed -1.82 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20255.66%2,383,055$56.14MShares increased 25.50%; reported value increased 23.10%, and weight changed +0.50 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20256.25%2,807,836$81.60MShares increased 17.83%; reported value increased 45.33%, and weight changed +0.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20258.72%3,072,304$155.58MShares increased 9.42%; reported value increased 90.67%, and weight changed +2.47 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20265.76%2,173,286$87.43MShares decreased 29.26%; reported value decreased 43.80%, and weight changed -2.96 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20265.18%2,212,770$94.95MShares increased 1.82%; reported value increased 8.60%, and weight changed -0.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Eversept Partners, LP · VERA THERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1697013","quarter":"2026Q2","cusip":"92337R101"}

get_institutional_manager_history
{"cik":"1697013","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.